Dr. Van Laer, Gastroenterologie SRL
Dr. Van Laer, Gastroenterologie reported total assets of 81,282 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Jun 2026).
The score of Dr. Van Laer, Gastroenterologie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -18 % Total assets +10 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Van Laer, Gastroenterologie's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Jun 2026
- Year ended 31 Dec 2024filed on 17 Jul 2025
- Year ended 31 Dec 2023filed on 15 Jul 2024
- Year ended 31 Dec 2022filed on 25 Aug 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
Dr. Van Laer, Gastroenterologie's financial analysis
- Solvency69.7%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Van Laer, Gastroenterologie
Dr. Van Laer, Gastroenterologie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0737.648.079
- VAT number
- No VAT activity declared to the CBE
- Peppol
- Registered · 0208:0737648079 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Nov 2019
- Registered office
- 1730 Asse
- Latest accounts
- 2025 · filed on 26 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Van Laer, Gastroenterologie (SRL) has been based in Asse since 2019, active in: medical specialists activities. For 2025, it reports a net profit of 36,707 € and equity of 56,684 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Van Laer, Gastroenterologie
Companies in the same business, of comparable size and area, outside its group.
- Seghimmo Installation of industrial machinery and equipment Ath · balance sheet 81,288 €
- Rosameel Computer programming activities Woluwe-Saint-Lambert · balance sheet 81,204 €
- Sargos Market research and public opinion polling Woluwe-Saint-Pierre · balance sheet 81,201 €
- Sysplasma Manufacture of electronic components Ghent · balance sheet 81,197 €
- Vita4Care Nursing and midwifery activities Opwijk · balance sheet 106,110 €
- Kinesitherapeute Tien le Sports and recreation education Kalmthout · balance sheet 81,176 €
Frequently asked questions about Dr. Van Laer, Gastroenterologie
What is the revenue of Dr. Van Laer, Gastroenterologie?
Dr. Van Laer, Gastroenterologie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Van Laer, Gastroenterologie?
According to the Crossroads Bank for Enterprises, no VAT-liable activity is declared for Dr. Van Laer, Gastroenterologie. If it is VAT-registered, its VAT number is its company number prefixed with BE: BE0737648079. Its company number (CBE) is 0737.648.079.
Where is the registered office of Dr. Van Laer, Gastroenterologie?
According to the CBE register, the registered office of Dr. Van Laer, Gastroenterologie is in 1730 Asse.
What is the equity of Dr. Van Laer, Gastroenterologie?
At the close of the 2025 financial year, the equity of Dr. Van Laer, Gastroenterologie amounts to 56,684 €, a solvency of 69.7% of total assets.
Who manages Dr. Van Laer, Gastroenterologie?
The register lists 1 active mandates at Dr. Van Laer, Gastroenterologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dr. Van Laer, Gastroenterologie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →